Release Date: November 06, 2024
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
- Raia Drogasil SA (RADLY, Financial) reported a record-breaking quarter with the opening of 72 new stores, bringing the total to 3,139 units.
- The company achieved a strong Net Promoter Score (NPS) of 91%, indicating high customer satisfaction.
- Gross revenue increased by 15% to BRL10.7 billion, with a notable 40.2% growth in digital sales.
- Adjusted EBITDA grew by 23.2% to BRL810 million, with a margin of 7.5%, driven by a reduction in G&A expenses.
- Raia Drogasil SA (RADLY) is expanding its presence in smaller towns, enhancing its market reach and competitive edge.
Negative Points
- The company faces challenges with regulatory price increases and potential changes in taxation, which could impact future margins.
- There is a noted deceleration in market share gains, with increased competition in certain regions.
- The health services segment is still not profitable, with a reported loss, and regulatory changes are needed for it to take off.
- Personnel costs may rise due to a heated labor market, potentially impacting selling expenses.
- The company experienced a temporary undersupply of Ozempic due to strategic shifts by suppliers, affecting operations.
Q & A Highlights
Q: Can you provide more details about the expected margin improvements and any potential risks from regulatory price increases or taxation changes?
A: Marcilio Pousada, CEO: The dilution of G&A expenses is expected to continue, contributing to margin improvements. We are committed to maintaining high productivity in our stores and will invest in personnel if necessary to enhance customer service. Regulatory price increases are a regular occurrence, and we have strategies to mitigate their impact. Our working capital management remains efficient, with a focus on optimizing inventory levels.
Q: What are your plans for expanding into smaller towns, and how is the digital business contributing to growth?
A: Marcilio Pousada, CEO: We are expanding into smaller towns with populations under 50,000, which is part of our strategy to increase market presence. Our digital business is growing, with a significant portion of sales now coming from the app. This multichannel approach is enhancing customer reach and engagement, contributing to overall growth.
Q: How is the health services segment performing, and what are the expectations for breakeven?
A: Marcilio Pousada, CEO: Health services are becoming increasingly important, with a growing number of services performed in our pharmacies. We are seeing a shift in consumer behavior towards using pharmacies for primary care services. While the segment is not yet at breakeven, we expect improvements as the market adapts and regulatory changes occur.
Q: Can you elaborate on the impact of digital sales on gross margins and the main detractors of NPS for the app?
A: Marcilio Pousada, CEO: Digital sales have a controlled impact on gross margins, and we are continuously improving our digital platform. The NPS for our app has improved significantly, but we are focused on further enhancements, such as faster search speeds, to close the gap with physical stores.
Q: What is the company's approach to managing personnel costs amid a heated labor market?
A: Marcilio Pousada, CEO: We focus on training and retaining employees, ensuring that our stores are staffed with well-prepared personnel. Our unit economics allow us to dilute fixed expenses as sales grow, and we are committed to maintaining a positive work environment to attract and retain talent.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
